Wordt geladen...
Interleukin-21 in cancer immunotherapy: Friend or foe?
Interleukin (IL)-21, a cytokine produced by activated conventional CD4+ T lymphocytes and Natural Killer T cells, drives anti-tumor immunity in the skin and kidney. However IL-21 is also pro-inflammatory in many tissues and promotes colitis-associated colon cancer. Understanding the biology of IL-21...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Landes Bioscience
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3382872/ https://ncbi.nlm.nih.gov/pubmed/22737612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.19122 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|